Effects of the rate of solvent evaporation on the characteristics of drug loaded PLLA and PDLLA microspheres

International Journal of Pharmaceutics

Volumn 212, Issue 2, 2001, Pages 161-169

  Chung, Tze Wen ^a   Huang, Yi You ^b   Liu, Yi Ze ^a  

^a CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Microspheres; Poly D,L lactatide; Poly L lactatide; Solvent evaporation

Indexed keywords

LIDOCAINE; MICROSPHERE; POLYGLACTIN; POLYLACTIC ACID; POLYLACTIDE;

ARTICLE; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; EVAPORATION; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

LIDOCAINE; MICROSPHERES; PARTICLE SIZE; POLYESTERS; SOLVENTS; VOLATILIZATION;

EID: 0035895291     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(00)00574-3     Document Type: Article

References (21)

1. Preparation of biodegradable microspheres and microencapsules: 2. Polylactides and related polyesters
2. Incorporation and release of vanco-mycin from poly(D,L-lactide-co-glycolide) microspheres
3. Use of polylactic acid for the preparation of microparticulate drug delivery system
4. Poly(lactide-co-glycolide) microspheres
5. Biodegradable microspheres for sustained delivery of tetracycline to the perioclotal pocket: Formulatory and drug release studies
6. Tissue response and in vivo degradation of selected polyhydroxyacid: Polylactides (PLA), poly (3-hydrobutyrate) (PHB), and poly (3-hydrobutyrate-co-3-hydroxy-valerate) (PHB/VA)
7. Preparation of poly (D,L) latide microspheres by emulsion-solvent evaporation, and their clinical applications as a convenient embolic materials
8. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pig to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of polylactide-co-glycolide polymers
9. Characterization of biodegradabe poly(D,L-lactide-co-glycolide) polymers and microspheres
10. Drug release from PLA/PEG microparticles
11. A method using PLA/PEG for drug release with reduced initial burst
12. Preparation of poly(L-lactide) microspheres of different crystalline morphology and effect of crystalline morphology on drug release rate
13. Effects of solvent removal technique on the matrix characteristics of polylactide/glycolide microspheres for peptide delivery
14. Effect of processing parameters on the properties of peptide-containing PLGA microspheres
15. In vitro controlled release kinetics of local anaesthetics from poly (D,L-lactide) and poly (lactide-co-glycolide) microspheres
16. Prediction of solvent removal profile and effect on properties for peptide-loaded PLGA microspheres prepared by solvent extraction/evaporation method
17. Double walled polymer microspheres for control release
18. The influence of biodegradable micro-encapsule formations on controlled release of a protein
19. Porous biodegradable microspheres for controlled drug delivery. I. Assessment of processing conditions and solvent removal technique
20. Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion method